Nutex Health, Inc. (NUTX) Earnings History
Annual and quarterly earnings data from 2010 to 2025
Loading earnings history...
NUTX EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
NUTX Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 50.8% | 31.5% | 8.1% |
| 2024 | 40.9% | 27.2% | 10.9% |
| 2023 | 14.0% | -12.8% | -18.5% |
| 2022 | 7.0% | -185.4% | -193.7% |
| 2021 | 54.1% | 51.4% | 40.0% |
Download Data
Export NUTX earnings history in CSV or JSON format
Free sign-in required to download data
Nutex Health, Inc. (NUTX) Earnings Overview
As of May 8, 2026, Nutex Health, Inc. (NUTX) reported trailing twelve-month net income of $96M, reflecting +7.9% year-over-year growth. The company earned $13.43 per diluted share over the past four quarters, with a net profit margin of 8.1%.
Looking at the long-term picture, NUTX's 5-year EPS compound annual growth rate (CAGR) stands at -15.8%, signaling declining earnings. The company achieved its highest annual net income of $133M in fiscal 2021.
Nutex Health, Inc. maintains positive profitability with a gross margin of 50.8%, operating margin of 31.5%, and net margin of 8.1%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including ADUS ($100M net income, 6.7% margin), AMSF ($46M net income, 14.9% margin), UHS ($1.52B net income, 8.6% margin), NUTX has outperformed on profitability metrics. Compare NUTX vs ADUS →
NUTX Earnings vs Peers
Earnings metrics vs comparable public companies
NUTX Historical Earnings Data (2010–2025)
13 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $71M | +35.7% | $276M | $10.48 | 8.1% | 31.5% |
| 2024 | $52M | +214.0% | $131M | $9.71 | 10.9% | 27.2% |
| 2023 | -$46M | +89.2% | -$32M | $-10.39 | -18.5% | -12.8% |
| 2022 | -$425M | -420.4% | -$407M | $-100.36 | -193.7% | -185.4% |
| 2021 | $133M | +25.1% | $170M | $33.55 | 40.0% | 51.4% |
| 2020 | $106M | +406.5% | $153M | $24.69 | 38.7% | 55.9% |
| 2019 | $21M | +843.5% | $35M | $3.98 | 21.6% | 35.8% |
| 2018 | -$3M | -583.5% | -$2M | $-0.39 | -3080.0% | -2003.4% |
| 2017 | $582,062 | +107.8% | -$6M | $0.14 | 1085.0% | -10611.8% |
| 2016 | -$7M | -8968.1% | $-448,600 | $-3.60 | - | - |
See NUTX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NUTX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NUTX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNUTX — Frequently Asked Questions
Quick answers to the most common questions about buying NUTX stock.
Is NUTX growing earnings?
NUTX EPS stands at $13.43, with +7.9% growth matching the 5-year CAGR of -15.8%. TTM net income is $96M. Earnings trajectory remains consistent.
What are NUTX's profit margins?
Nutex Health, Inc. net margin is +8.1%, with operating margin at +31.5%. Margins sit within typical range for the sector.
How consistent are NUTX's earnings?
NUTX earnings data spans 2010-2025. The current earnings trend is +7.9% YoY. Historical data enables comparison across business cycles.